However, the most advanced studies for P/ERT as a possible treatment approach for mitochondrial diseases is the use of the TAT delivery system for the mitochondrial frataxin (FXN) protein, involved in Friedreich’s ataxia (FRDA). The gene discussed is FXN; the disease is Friedreich ataxia.